NanoVibronix Secures $12M Minimum Purchase Commitment for PainShield 

NanoVibronix Inc. has renewed its exclusive PainShield distribution agreement with Ultra Pain Products Inc. (UPPI) for another five years.

“We are thrilled to extend our partnership with Ultra Pain Products for another five years and secure a minimum purchase commitment of our products valued at $12 million,” NanoVibronix CEO Brian Murphy said. “UPPI’s growth, transition into manufacturing, and dedication to innovation align perfectly with our values and goals. Their ability to deliver affordable and effective solutions to patients makes them an ideal partner to help us continue to make a difference.”

The company decided to renew the distribution agreement based on UPPI’s growth over the past four years and its evolution into a significant force in the non-opioid pain management and injury recovery industry. The renewed agreement underscores the continued collaboration between the two companies and ensures that NanoVibronix’s proprietary PainShield product is a part of Ultra Pain Products’ expanding portfolio of technologies.

“We are honored to continue our exclusive distribution agreement with NanoVibronix. We view our partnership as a collaboration that strengthens each organization’s impact in the market,” Ultra Pain Products President Ari Alayev stated. “This renewal is a testament to our shared vision and the mutual trust we have built over the past four years. We are excited to continue to offer PainShield as part of our growing roster of technologies as we continue to expand our offerings and lead the charge in non-opioid treatment options.”

The agreement reflects the companies’ mutual dedication to supporting injury recovery and empowering patients with advanced solutions that prioritize safety, efficacy, and accessibility.

NanoVibronix Inc. is a medical device company headquartered in Tyler, Texas, with research and development in Nesher, Israel, that develops medical devices using its patented low intensity surface acoustic wave technology. The proprietary technology creates low-frequency ultrasound waves that can be used for various medical applications, including for disrupting biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without assistance from medical professionals. The company’s primary products include the UroShield, PainShield, and WoundShield Surface Acoustic Wave Portable Ultrasonic Therapeutic Devices.